Amphastar Pharmaceuticals (AMPH) Non-cash Items (2016 - 2025)
Amphastar Pharmaceuticals has reported Non-cash Items over the past 13 years, most recently at $4.7 million for Q4 2025.
- Quarterly results put Non-cash Items at $4.7 million for Q4 2025, down 75.23% from a year ago — trailing twelve months through Dec 2025 was $4.7 million (down 75.23% YoY), and the annual figure for FY2025 was $4.7 million, down 75.23%.
- Non-cash Items for Q4 2025 was $4.7 million at Amphastar Pharmaceuticals, down from $4.8 million in the prior quarter.
- Over the last five years, Non-cash Items for AMPH hit a ceiling of $304.8 million in Q2 2023 and a floor of $500000.0 in Q2 2021.
- Median Non-cash Items over the past 5 years was $10.5 million (2021), compared with a mean of $68.2 million.
- Biggest five-year swings in Non-cash Items: skyrocketed 5280.76% in 2023 and later plummeted 97.17% in 2025.
- Amphastar Pharmaceuticals' Non-cash Items stood at $500000.0 in 2021, then soared by 2800.0% to $14.5 million in 2022, then tumbled by 60.79% to $5.7 million in 2023, then skyrocketed by 235.92% to $19.1 million in 2024, then tumbled by 75.23% to $4.7 million in 2025.
- The last three reported values for Non-cash Items were $4.7 million (Q4 2025), $4.8 million (Q3 2025), and $20.0 million (Q2 2025) per Business Quant data.